Navigation Links
The Zika Virus Report
Date:2/19/2016

LONDON, February 19, 2016 /PRNewswire/ --

Implications of the Rapid Spread of Zika with a Focus on the Infectious Disease Diagnostics Market and Human Vaccines Market 

What can be expected as the Zika outbreak progresses? Which areas are going to be the most affected? This visiongain report discusses the future direction of the Zika virus outbreak and the implications of its spread. It also discussed the infectious disease diagnostics market and the global human vaccines market, both of which are forecast to 2026. The pipeline for Zika virus diagnostics and vaccines is explored.

Our 78-page report provides 28 tables, charts, and graphs. Understand the virus and the future of the current outbreak. Our new study lets you assess the impact the virus might have on a number of regions, and the complications that have so far been associated with it.

Forecasts from 2016-2026 and other analyses show you commercial prospects
This report provides forecasts for both the infectious disease diagnostics market and the human vaccines market to 2026, and discussed the possible future contributors to these markets in relation to the Zika virus. Discover the symptoms, transmission, history and economic and social impacts of this virus.

See revenue forecasts for the associated markets
How will associated markets perform to 2026? Our study forecasts revenues in the following related markets:
• Infectious Disease Diagnostics Market
• Global Vaccines Market

Leading Vaccine Manufacturers and Companies Searching for a Zika Virus Vaccine
The number of patients infected with the Zika virus is predicted to soar, and the need for a vaccine is becoming ever more apparent. We discuss some of the leading international vaccine manufacturing companies, and then take a look at the companies that are currently developing vaccines or the Zika virus.

Companies included in this report include:
• GlaxoSmithKline
• Merck
• Pfizer
• Sanofi
• Bharat Biotech
• Inovio Pharmaceuticals

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

What does the Zika virus outbreak mean for the future?
Our new report discusses issues and events regarding the Zika virus outbreak, currently in Central and South America. You will find discussions, including analysis of past outbreaks, the virus' modes of transmission, symptoms. Future trends include:
• Increasing economic and social pressures related to the virus
• Development of a vaccine will lead to large financial returns
• The virus is likely to spread from its current territories, to include the US and possibly much of Southern Europe, Africa and Asia.

How the Zika Virus Report report helps you
In summary, our 78-page report gives you the following knowledge:
• Understanding of the structure, replication mechanisms and transmission modes of the Zika virus
• An in-depth history of previous Zika virus outbreaks and detail the viruses spread from Africa
• Study of the potential spread of the virus, looking at the areas in which the virus' vectors are able to survive on a global scale
• Intelligence on important markets that will be affected by the Zika virus outbreak
• Revenue forecast for the Infectious Disease Diagnostics Market covering the period 2016 to 2026
• Revenue forecast for the Global Vaccines Market covering the period 2016 to 2026.
• Profiles of leading companies operating within the vaccines market
• Significant social and economic issues arising from the spread of the Zika virus
• Conclusions and recommendations

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the cholesterol-lowering drugs market and leading companies. You will find data, trends and predictions. Please order our report now.

Companies mentioned
Baxter
Bharat Biotech
CSL
GeneOne Life Sciences
GlaxoSmithKline
GlaxoWellcome
Inovio Pharmaceuticals
Merck
Novarits
Pfizer
Regulus Therapeutics
Sanofi
SmithKline Beecham
Takeda Pharmaceuticals

To request an exec summary of this report please email Sara Peerun at sara.peerun@visiongainglobal.com  or call Tel: +44(0)-20-7336-6100

Or click on https://www.visiongain.com/Report/1579/The-Zika-Virus-Report

 


'/>"/>
SOURCE Visiongain
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Gharda Chemicals fornece formulações para refrear surto do vírus zika
2. RB Pledges $1 Million Zika Relief Package To Fight Spread Of Virus
3. Ennaid Therapeutics Prioritizes Zika Virus Rapid Drug Development in Wake of Crisis
4. Eiger BioPharmaceuticals Announces Completion of Enrollment of Phase 2 LOWR HDV - 3 (LOnafarnib With Ritonavir in Hepatitis Delta Virus - 3) Study at National Institutes of Health (NIH)
5. Janssen Announces Collaboration with Bavarian Nordic to Develop Vaccine for Chronic Human Papillomavirus (HPV) Infections
6. Yisheng Biopharma und das United States Army Medical Research Institute of Infectious Diseases verkünden Zusammenarbeit an neuem Impfstoff gegen das Ebolavirus
7. Samenwerking tussen Yisheng Biopharma en het United States Army Medical Research Institute of Infectious Diseases aan een nieuw vaccin tegen ebolavirus
8. Yisheng Biopharma and the United States Army Medical Research Institute of Infectious Diseases Announce Collaboration on New Vaccine Against Ebola Virus
9. Hologic amplia il proprio portafoglio europeo per la virologia con il test certificato CE-IVD per la carica virale del virus dellepatite B (HBV)
10. Hologic erweitert sein Virologie-Portfolio in Europa mit einem CE-IVD-zertifizierten Assay zur Hepatitis B Virus (HBV) Viruslast-Testung
11. Profectus BioSciences Receives $4.6 Million DOD Grant to Develop Vaccine for Western, Eastern, and Venezuelan Equine Encephalitis Viruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2019)... (PRWEB) , ... September 18, ... ... parent organization to ReachMD, Global Learning Collaborative, and other healthcare-focused subsidiaries, today ... environment, DecisionSim™, uses real-world cases to challenge healthcare professionals (HCPs) to make ...
(Date:9/18/2019)... ... 2019 , ... The interns of NJ Lenders Corp. recently spent their time ... Foundation (YCS) in Hackensack , where NJ Lenders donated $1,000 worth of school supplies ... them a pizza party and handed out ice cream. , NJ Lenders is a ...
(Date:9/18/2019)... ... ... U.S. Dermatology Partners was a proud sponsor of the 9th Annual ... took place at Lake Ray Hubbard in Rockwall. Over 340 swimmers raised $270,000 and ... helps fund phase 1 clinical trials for cancer research for difficult to treat cancers ...
Breaking Medicine Technology:
(Date:9/17/2019)... ... September 17, 2019 , ... ... Keflezighi and the American Heart Association (AHA)-San Diego Chapter to raise awareness of ... Stroke Walk on Saturday, September 21 in Balboa Park alongside National University System ...
(Date:9/17/2019)... ... 2019 , ... Drs. Charles Felts and Elizabeth Felts Randall ... TN for customized full mouth dental implants with TeethXpress® . TeethXpress treatment ... a permanent tooth replacement solution for patients who struggle with the pain and ...
(Date:9/17/2019)... ... September 17, 2019 , ... Specialty Technical ... updated International Audit Protocol Consortium (IAPC) EHS audit protocol for Japan . ... scope of their EHS regulatory obligations and rapidly collect, share, archive, and export ...
(Date:9/14/2019)... ... September 13, 2019 , ... ... on the detection and treatment of infectious diseases at its annual Congress ... were noninvasive detection of residual HIV infected cell persistence and the development ...
(Date:9/11/2019)... ... ... A September 2 article on CBS News details a new ... to suffer heart attacks, strokes, kidney failure, and heart disease versus a control group ... specialists Dr. Feiz and Associates says the study adds further evidence to an overwhelming ...
Breaking Medicine News(10 mins):